Clinical Trial Update: Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial assessing the effects of vaginal oxytocin gel on vaginal cytology in postmenopausal women with vaginal atrophy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Conditions
• Vaginal Atrophy

Drugs mentioned

• oxytocin gel (oxytocin)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Vaginal Atrophy, Oxytocin Gel | Phase 2, Phase 3 | Status: TERMINATED